XPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
XPHARMA
Largest movements
- Tangible fixed assets +€231,000
up €231,000 (+21.1%), from €1.1m to €1.3m
- Cash +€96,088
up €96,088 (+1125.5%), from €8,537 to €104,625
mainly Net result for the year (+€318,475) and Other debts (+€130,052)
- Receivables within one year +€55,006
up €55,006 (+84.5%), from €65,079 to €120,085
of which Trade receivables: +€55,000
- Reserves +€258,950
up €258,950 (+42.3%), from €612,406 to €871,356
- Other debts +€130,052
up €130,052 (+58.5%), from €222,437 to €352,489
- Debts after one year +€66,888
up €66,888 (+4.3%), from €1.6m to €1.6m
- Current portion of long-term debt -€53,585
down €53,585 (-27.8%), from €192,697 to €139,112
- Gross operating margin +€24,165
up €24,165 (+16.2%), from €148,899 to €173,064
- Depreciation +€16,597
up €16,597 (+25.4%), from €65,217 to €81,814
- Other operating charges +€5,261
up €5,261 (+13.0%), from €40,376 to €45,637
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,657,337 | €3,070,326 | +€412,989 | +15.5% |
| Fixed assets | 21/28 | €2,531,721 | €2,763,721 | +€232,000 | +9.2% |
| Tangible fixed assets | 22/27 | €1,092,284 | €1,323,283 | +€231,000 | +21.1% |
| Land and buildings | 22 | €1,092,284 | €1,323,283 | +€231,000 | +21.1% |
| Financial fixed assets | 28 | €1,439,437 | €1,440,437 | +€1,000 | +0.1% |
| Current assets | 29/58 | €125,616 | €306,605 | +€180,989 | +144.1% |
| Amounts receivable within one year | 40/41 | €65,079 | €120,085 | +€55,006 | +84.5% |
| Trade receivables | 40 | €65,000 | €120,000 | +€55,000 | +84.6% |
| Other amounts receivable | 41 | €79 | €85 | +€6 | +7.6% |
| Current investments | 50/53 | €52,000 | €70,000 | +€18,000 | +34.6% |
| Cash at bank and in hand | 54/58 | €8,537 | €104,625 | +€96,088 | +1125.5% |
| Deferred charges and accrued income | 490/1 | €0 | €11,896 | +€11,896 | |
| Total equity and liabilities | 10/49 | €2,657,337 | €3,070,326 | +€412,989 | +15.5% |
| Equity | 10/15 | €631,006 | €889,956 | +€258,950 | +41.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €612,406 | €871,356 | +€258,950 | +42.3% |
| Distributable reserves | 133 | €612,406 | €871,356 | +€258,950 | +42.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €2,026,331 | €2,180,370 | +€154,039 | +7.6% |
| Amounts payable after more than one year | 17 | €1,569,540 | €1,636,429 | +€66,888 | +4.3% |
| Financial debts | 170/4 | €1,569,540 | €1,636,429 | +€66,888 | +4.3% |
| Amounts payable within one year | 42/48 | €456,790 | €535,609 | +€78,819 | +17.3% |
| Current portion of amounts payable after more than one year | 42 | €192,697 | €139,112 | -€53,585 | -27.8% |
| Trade debts | 44 | €7,544 | €8,347 | +€803 | +10.6% |
| Suppliers | 440/4 | €7,544 | €8,347 | +€803 | +10.6% |
| Taxes, remuneration and social security | 45 | €34,112 | €35,661 | +€1,549 | +4.5% |
| Taxes | 450/3 | €34,112 | €35,661 | +€1,549 | +4.5% |
| Other amounts payable | 47/48 | €222,437 | €352,489 | +€130,052 | +58.5% |
| Accrued charges and deferred income | 492/3 | - | €8,332 | +€8,332 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €65,217 | €81,814 | +€16,597 | +25.4% |
| Other operating charges | 640/8 | €40,376 | €45,637 | +€5,261 | +13.0% |
| Gross operating margin | 9900 | €148,899 | €173,064 | +€24,165 | +16.2% |
| Operating profit (loss) | 9901 | €43,307 | €45,613 | +€2,306 | +5.3% |
| Financial income | 75/76B | €350,111 | €350,503 | +€393 | +0.1% |
| Recurring financial income | 75 | €350,111 | €350,503 | +€393 | +0.1% |
| Financial charges | 65/66B | €42,789 | €43,182 | +€393 | +0.9% |
| Recurring financial charges | 65 | €42,789 | €43,182 | +€393 | +0.9% |
| Profit (loss) for the period before taxes | 9903 | €350,629 | €352,935 | +€2,306 | +0.7% |
| Income taxes | 67/77 | €34,082 | €34,460 | +€378 | +1.1% |
| Profit (loss) for the period | 9904 | €316,547 | €318,475 | +€1,928 | +0.6% |
| Profit (loss) for the period to be appropriated | 9905 | €316,547 | €318,475 | +€1,928 | +0.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 August 2024 and 31 August 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.